Cannabics Pharmaceuticals Inc. announced earnings results for the third quarter ended May 31, 2021. For the third quarter, the company announced sales was USD 0 compared to USD 1,886 a year ago. Operating loss was USD 676,252 compared to USD 690,514 a year ago. Net loss was USD 1.323 million compared to USD 725,675 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.05 a year ago. For the nine months, sales was USD 0 compared to USD 4,950 a year ago. Operating loss was USD 2.003 million compared to USD 2.372 million a year ago. Net loss was USD 2.513 million compared to USD 6.735 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.05 a year ago.